The Cancer Gene Therapy market is a subset of the larger Genomics market, which focuses on the study of genes and their functions. Cancer Gene Therapy is a form of treatment that uses genetic material to treat or prevent cancer. It involves introducing genetic material into cells to modify their behavior, such as to stop the growth of cancer cells or to make them more sensitive to chemotherapy. This type of therapy has the potential to be more effective and less toxic than traditional treatments. Cancer Gene Therapy is still in its early stages of development, but it has the potential to revolutionize cancer treatment. It is being studied in clinical trials and is expected to become more widely available in the future. Companies in the Cancer Gene Therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Allergan. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
